UBS Group
RNA

UBS Group’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History

UBS Group’s Portfolio RNA Stock Details RNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-122
Closed -$2K – 10074
2014
Q4 		$2K Buy
+122
New +$1.73K ﹤0.01% 9504

UBS Group's RNA Position: Q1 2015 in Review

UBS Group sold out of PROSENSA HLDGS N V ORD SHS (NLD) (RNA) in Q1 2015, closing a stake of 122 shares — an estimated $2K sold.

UBS Group first reported a position in RNA in Q4 2014 and held it in 1 quarter. The position peaked at $2K in Q4 2014. 0 funds tracked by Wall St. Rank hold RNA as of Q1 2015.

  • UBS Group reported no remaining PROSENSA HLDGS N V ORD SHS (NLD) position as of Q1 2015 after selling out during the quarter.
  • UBS Group sold 122 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q1 2015, an estimated $2K.
  • UBS Group first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q4 2014 and held it in 1 quarter.
  • UBS Group's PROSENSA HLDGS N V ORD SHS (NLD) position peaked at $2K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q1 2015.

Based on UBS Group's 13F filing for Q1 2015, filed 14 May 2015.